References
- Aghajanian G K. Tolerance of locus coeruleus neurons to morphine and suppression of withdrawal response by clonidine. Nature 1978; 276: 186–8
- Andén N E., Corrodi H, Fuxe K, et al. Evidence for a central noradrenaline receptor by clonidine. Life Sci 1970; 9(1)513–23
- Andén N E., Grabowska M, Strömbom U. Different alpha-adrenoreceptors in the central nervous system mediating biochemical and functional effects on clonidine and receptor blocking agents. Naunyn-Schmiede-berg's Arch Pharmacol 1976; 292: 43–52
- Andén N E., Strömbom U. Adrenergic receptor blocking agents: Effects on central noradrenaline and dopamine receptors and on motor activity. Psychopharmacologia 1974; 38: 91–103
- Andén N E., Strömbom U, Svensson T H. Dopamine and noradrenaline receptor stimulation: Reversal of reserpine-induced suppression of motor activity. Psycho-pharmacologia 1973; 29: 289–98
- Aston-Jones G, Bloom F E. Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle. J Neurosci 1981; 1: 876–86
- Aston-Jones G, Bloom F E. Norepinephrine-containing locus coeruleus neurons in behaving rats exhibit pronounced responses to non-noxious environmental stimuli. J Neurosci 1981; 1: 887–900
- Björkqvist S E. Clonidine in alcohol withdrawal. Acta Psychiat Scand 1975; 52: 256–63
- Bousquet P, Rouot B, Schwartz J. The central α-adrenoceptors: Some new aspects. Trends Pharmacol Sci 1983; 206–8
- Cohen D J., Detlor J, Young G, Shaywitz B A. Clonidine Ameliorates Gilles de la Tourette Syndrome. Arch Gen Psychiatry 1980; 37: 1350–7
- Elam M, Svensson T H., Thoren P. Differentiated cardiovascular afferent regulation of locus coeruleus neurons and sympathetic nerves. Brain Research 1985, in press
- Elam M, Svensson T H., Thorén P. Locus coeruleus neurons and peripheral sympathetic nerves: Activation by visceral afferents. 1985, Manuscript submitted
- Elam M, Yao T, Svensson T H., Thorén P. Regulation of locus coeruleus neurons and splanchnic, sympathetic nerves by cardiovascular afferents. Brain Res 1984; 290: 281–7
- Elam M, Yao T, Thoren P, Svensson T H. Hypercapnia and hypoxia: Chemoreceptor mediated control of central norepinephrine neurons and splanchnic, sympathetic nerves. Brain Res 1981; 222: 373–81
- Eriksson E, Modigh K. Depression, α2-receptors and sex hormones: Neuroendocrine studies in rat. Adv Biochem Psychopharmacol 1984; 39: 161–78
- Foote S L., Aston-Jones G, Bloom F E. Impulsive activity of locus coeruleus neurons in awake rats and monkeys is a function of sensory stimulation and arousal. USA: Proc Natl Acad Sci 1980; 77: 3033–7
- Foote S L., Bloom F E., Aston-Jones G. Nucleus locus coeruleus: New evidence of anatomical and physiological specificity. Physiol Rev 1983; 63: 844–914
- Freedman R, Kirch D, Bell J, et al. Clonidine treatment of schizophrenia. Double-blind comparison to placebo and neuroleptic drugs. Acta Psychiat Scand 1982; 65: 35–45
- Glassman A H., Jackson W K., Walsh B T., Roose S P., Rosenfeld B. Cigarette craving, smoking withdrawal and clonidine. Science 1984; 226: 864–6
- Gold M S., Pottash A LC, Extein J. Clonidine: Inpatient studies from 1978 to 1981. J Clin Psychiatry 1982; 43: 35–8, sec2
- Gold M S., Redmond D E., Jr, Kleber H D. Clonidine blocks acute opiate withdrawal symptoms. Lancet 1978; 2: 599–602
- Hoefke W, Jennewein H M. Mechanism of antihypertensive action of clonidine in relation to its psychotropic effects. Psychopharmacology of Clonidine, H Lai, S Fielding. Alan R. Liss Inc., New York 1981; 75–97
- Hoehn-Saric R, Merchant A F., Keyser M L., Smith V K. Effects of clonidine on anxiety disorders. Arch Gen Psychiatry 1981; 38: 1278–82
- Korf J, Bunney B S., Aghajanian G K. Noradrenergic neurons: Morphine inhibition of spontaneous activity. Europ J Pharmacol 1974; 25: 165–9
- Liebowitz M R., Fyer A J., McGrath P, Klein D F. Clonidine treatment of panic disorder. Psychopharmacol Bull 1981; 17: 122–3
- Strömbom U, Svensson T H. Clonidine: Attenuation of sedative action by facilitated central noradrenergic neurotransmission. J Neural Transmission 1980; 47: 29–39
- Svensson T H., Waldeck B. On the significance of central noradrenaline for motor activity: Experiments with a new dopamine-β-hydroxylase inhibitor. Europ J Pharmacol 1969; 7: 278–82
- Svensson T H. On the role of central noradrenaline in the regulation of motor activity and body temperature in the mouse. Naunyn-Schmiedeberg's Arch Pharmacol 1971; 271: 111–20
- Svensson T H. Central α-adrenoceptors and affective symptoms and disorders. Depressive Disorders, E Lindenlaub, S Garrattini. Schattauer Verlag, Stuttgart-New York 1978; 245–54
- Svensson T H. Emerging aspects of the adrenergic systems. Acta Anaesth Scand 1982; 76: 8–11
- Svensson T H., Bunney B S., Aghajanian G K. Inhibition of both noradrenergic and serotonergic neurons in brain by the α-adrenergic agonist clonidine. Brain Res 1975; 92: 291–306
- Svensson T H., Persson R, Wallin L, Wålinder J. Anxiolytic action of clonidine. Nord Psyk Tidskr 1978; 32: 439–41
- Svensson T H., Thoren P. Brain noradrenergic neurons in the locus coeruleus: Inhibition by blood volume load through vagal afferents. Brain Res 1979; 172: 174–8
- Van Dongen P AM. The central noradrenergic transmission and the locus coeruleus: A review of the data and their implications for neurotransmission and neuromodulation. Progr Neurobiol 1981; 16: 117–43
- Wålinder J, Balldin J, Bokström K, Karlsson J, Lund-ström B, Svensson T H. Clonidine suppression of the alcohol withdrawal syndrome. Drug and Alcohol Dependence 1981; 8: 345–8
- Walinder J, Svensson T H. The use of clonidine in anxiety and withdrawal states. Alpha-Adrenoceptors In Hypertensive Disease, M Frisk-Holmberg, M Henning, 1983; Series Vol. 40: 31–5, Wenner-Gren Symp, Trosa Tryckeri AB
- Zebrowska-Lupina J, Przegalinski E, Sloniec M, Keinrok Z. Clonidine-induced locomotor hyperactivity in rats. The role of central postsynaptic α-adrenoceptors. Naunyn-Schmiedeberg's Arch Pharmacol 1977; 297: 227–31